MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. (Q50547274)

15 March 2018

title

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. (English)

1 reference

15 March 2018

author

Mohammed A Aleskandarany

Mohammed A Aleskandarany

1

0 references

Emad A. Rakha

Emad A Rakha

2

0 references

Andrew Green

Andrew R Green

6

0 references

Ian Ellis

Ian O Ellis

5

0 references

author name string

R Douglas Macmillan

3

1 reference

15 March 2018

Desmond G Powe

4

1 reference

15 March 2018

language of work or name

English

0 references

publication date

11 July 2010

1 reference

15 March 2018

Breast Cancer Research and Treatment

published in

1 reference

15 March 2018

volume

127

1 reference

15 March 2018

issue

3

1 reference

15 March 2018

page(s)

591-599

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1007/s10549-010-1028-3

exact match

0 references

cites work

An overview of prognostic factors for long-term survivors of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Histologic grading of breast carcinoma. A reproducibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Understanding the molecular basis of histologic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Common markers of proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Review: assessment of cell proliferation in histological material

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Comparison of prognostic gene expression signatures for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Expression profiling technology: its contribution to our understanding of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Effect of fixatives and tissue processing on the content and integrity of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Molecular evolution of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Pathological prognostic factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1028-3

10.1007/S10549-010-1028-3

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018